Federal Register Final order: The FD&C Act authorizes FDA to award priority review vouchers (PRVs) to tropical disease product applicants when the applications meet certain criteria. It also lists the diseases that are considered to be tropical diseases for purposes of obtaining PRVs. FDA is adding Chagas disease and neurocysticercosis to the list of designated tropical diseases, To view this notice, click here.
